Unveiling the Power of Real-World Evidence: Transforming Medical Research & Patient Care
Date: October 4, 2024
Duration: 60 Minutes
Time: 12 PM EST
The FDA has already recognized the immense value of Real World Evidence. As traditional clinical trials become increasingly expensive and time-consuming, the need for alternative approaches has never been more critical. RWE provides the clinical evidence we need to make informed decisions about the safety, efficacy, and real-world performance of medical products.
Why should I attend:
- Empowering Therapeutic Development and Patient Care: Our seminar will showcase how RWE has the power to inform therapeutic development, outcomes research, patient care, and research on healthcare systems. By analyzing data routinely collected from various sources, including electronic health records, RWE offers a comprehensive and generalizable solution that benefits both patients and the healthcare industry.
- Accelerated Pathways to Drug Approval: In a landscape where more drugs are being approved through accelerated pathways, the FDA emphasizes the need for the best quality evidence. By attending our seminar, you will gain insights into how RWE can expedite the drug approval process without compromising on safety and efficacy, making it an indispensable asset for pharmaceutical companies.
- Affordable Solutions for All: The FDA’s endorsement of RWE extends beyond its generalizability; it also recognizes that real-world research is a much less expensive alternative to traditional clinical trials. Our seminar will explore the cost-saving potential of RWE, allowing you to optimize your research budget without compromising the integrity of your studies.
- Guidance and Industry Demand: While the FDA has been utilizing RWE for a long time, the entire research community and industry seek clear guidance on its best practices and implementation. At our seminar, we will discuss the latest guidelines and explore the possibilities of utilizing RWE to its fullest potential within the existing regulatory framework.
- Transparency, Controls, and Validation: Transparency, internal controls, and external validation are paramount when it comes to leveraging RWE effectively. Our seminar will equip you with the knowledge and tools needed to ensure the integrity of your research, building trust and credibility within the scientific community and beyond.
Gain a competitive edge by understanding what FDA thinks about RWE and how to leverage it effectively, leading to better-informed decisions, accelerated drug development, and improved patient outcomes.
Secure your spot today and pave the way for a brighter future of medical research with Real-World Evidence.
Speaker: Mukesh Kumar
PhD, RAC | CEO, FDAMap
For more info, fill the box below. We will contact you within 24 hrs.
Webinar Fee
Prices are in US Dollars.
The registration fee includes: The live webinar & all related course materials.
Terms & Conditions to register for the Webinar
Your Registration for the workshop is subject to following terms and conditions. If you need any clarification before registering for this webinar please email us at info@fdamap.com
Payment
We accept credit card, debit card, and PayPal.
Cancellations & Substitutions:
Written cancellations through fax or email (from the person who has registered for this conference) received at least 5 business days prior to the start date of the event will receive a refund — less a $30 administration fee. No cancellations will be accepted — nor refunds issued — within 5 business days before the start date of the event. You may however, choose to substitute the webinar for which you are registered with some other webinar in the future.
On request by email or fax (before the seminar) a credit for the amount paid minus administration fees ($30) will be transferred to any future FDA Map event and a credit note will be issued. No-shows will be charged the full amount.
Webinar material will be uploaded on the website 24 hours before the scheduled date of the webinar. In case it is not available on the website due to some technical issues, we will email the material a few hours before the start of the webinar.
In the event FDA Map cancels the webinar, FDA Map will issue a full refund to all the registrants for that webinar. Some topics and speakers may be subject to change without notice.
